SI
Sofinnova Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-359,035
| Closed | -$34.9M | – | 52 |
|
|
2023
Q1 | $34.9M | Sell |
359,035
-35,608
| -9% | -$3.46M | 2.23% | 11 |
|
|
2022
Q4 | $40.8M | Buy |
394,643
+99,893
| +34% | +$10.3M | 2.42% | 12 |
|
|
2022
Q3 | $25M | Sell |
294,750
-6,855
| -2% | -$581K | 1.45% | 13 |
|
|
2022
Q2 | $25M | Buy |
301,605
+125,072
| +71% | +$10.4M | 2.08% | 11 |
|
|
2022
Q1 | $13.6M | Buy |
176,533
+89,211
| +102% | +$6.88M | 1.03% | 21 |
|
|
2021
Q4 | $7.72M | Buy |
+87,322
| New | +$7.72M | 0.45% | 43 |
|
|
2021
Q1 | – | Sell |
-164,545
| Closed | -$14.4M | – | 65 |
|
|
2020
Q4 | $14.4M | Sell |
164,545
-94,108
| -36% | -$8.25M | 0.86% | 24 |
|
|
2020
Q3 | $19.7M | Buy |
258,653
+195,756
| +311% | +$14.9M | 1.46% | 16 |
|
|
2020
Q2 | $7.76M | Sell |
62,897
-177,149
| -74% | -$21.8M | 0.49% | 36 |
|
|
2020
Q1 | $20.3M | Sell |
240,046
-201,826
| -46% | -$17.1M | 1.88% | 15 |
|
|
2019
Q4 | $37.4M | Buy |
441,872
+356,976
| +420% | +$30.2M | 2.69% | 9 |
|
|
2019
Q3 | $5.72M | Hold |
84,896
| – | – | 0.52% | 39 |
|
|
2019
Q2 | $7.27M | Buy |
84,896
+66,402
| +359% | +$5.69M | 0.67% | 33 |
|
|
2019
Q1 | $1.64M | Sell |
18,494
-122,048
| -87% | -$10.8M | 0.16% | 53 |
|
|
2018
Q4 | $12M | Buy |
+140,542
| New | +$12M | 1.49% | 19 |
|